Home/Filings/4/0001878313-26-000016
4//SEC Filing

Smith Stan 4

Accession 0001878313-26-000016

CIK 0001878313other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:42 AM ET

Size

5.4 KB

Accession

0001878313-26-000016

Insider Transaction Report

Form 4
Period: 2025-12-31
Smith Stan
Director
Transactions
  • Award

    Options

    2025-12-31+29,21629,216 total(indirect: See footnote)
    Exercise: $1.53From: 2025-12-31Exp: 2035-12-31Common Stock (29,216 underlying)
Footnotes (2)
  • [F1]The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
  • [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913199

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:42 AM ET
Size
5.4 KB